course cystic fibrosis 95 patient course 95 patient cystic fibrosis presented survivor mean followup period 14 year minimum 13 year 45 patient diagnosed prior extensive irreversible pulmonary involvement one died none disabled contrast 50 patient diagnosed substantial irreversible pulmonary disease present 26 died mortality morbidity greater female possible factor contributing improving prognosis include early diagnosis aggressive management comprehensive care easy access specialized care improved antimicrobial therapy